田纳西州 的 急性髓系白血病 临床试验
田纳西州 有 31 项针对 急性髓系白血病 的研究正在招募参与者。
田纳西州 的城市
官方研究文本（英文）
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
招募中2 期
18 至 59 岁 · 所有性别 · 更新于 2026年9月28日 · NCT05554393A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
- University of Tennessee, Knoxville
- Vanderbilt Ingram Cancer Center, Nashville
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06852222MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT05564390A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
- Saint Jude Children's Research Hospital, Memphis
招募中1 期
21 岁及以下 · 所有性别 · 更新于 2026年9月23日 · NCT07012044Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT06317649Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
招募中2 期
18 至 59 岁 · 所有性别 · 更新于 2026年9月22日 · NCT05554406A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia
- St. Jude Children's Research Hospital, Memphis
招募中2 期
29 Days – 21 Years · 所有性别 · 更新于 2026年9月17日 · NCT05955261A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- T C Thompson Children's Hospital, Chattanooga
- East Tennessee Childrens Hospital, Knoxville
- The Children's Hospital at TriStar Centennial, Nashville
- 以及另外 1 项
招募中3 期
6 Months – 21 Years · 所有性别 · 更新于 2026年9月17日 · NCT04293562A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia
- St. Jude Children's Research Hospital, Memphis
招募中1 期
25 岁及以下 · 所有性别 · 更新于 2026年9月15日 · NCT06810583Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
- Sarah Cannon Center for Blood Cancer at TriStar Centennia, Nashville
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月14日 · NCT06846606A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Tristar Centennial Medical Center /ID# 275831, Nashville
招募中1 期
6 Months – 17 Years · 所有性别 · 更新于 2026年9月9日 · NCT07306832Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
- East Tennessee Childrens Hospital, Knoxville
- The Children's Hospital at TriStar Centennial, Nashville
招募中3 期
1 至 25 岁 · 所有性别 · 更新于 2026年9月4日 · NCT07022678CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)
- Sarah Cannon Research Insitute, Nashville
招募中1 期
18 至 85 岁 · 所有性别 · 更新于 2026年8月26日 · NCT06834282The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- East Tennessee Childrens Hospital, Knoxville
- Saint Jude Children's Research Hospital, Memphis
- The Children's Hospital at TriStar Centennial, Nashville
- 以及另外 1 项
招募中1/2 期
22 岁及以下 · 所有性别 · 更新于 2026年8月25日 · NCT04726241Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
- St. Jude Children's Research Hospital, Memphis
- Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville
招募中3 期
29 Days – 21 Years · 所有性别 · 更新于 2026年8月24日 · NCT05183035Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Vanderbilt University Medical Center, Nashville
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年8月20日 · NCT06001788Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- Baptist Clinical Research Institute, Memphis
- Tennessee Oncology, Nashville
- TriStar Centennial Medical Center, Nashville
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年8月20日 · NCT07007312Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
- Baptist Health Care Corporation, Memphis
- Vanderbilt University/Ingram Cancer Center, Nashville
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年8月19日 · NCT06399640Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
- St. Jude Children's Research Hospital, Memphis
招募中1 期
1 至 30 岁 · 所有性别 · 更新于 2026年8月3日 · NCT06177067Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Vanderbilt University, Ingram Cancer Center, Nashville
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年7月7日 · NCT07216443A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- St. Jude Childrens Research Hospital, Memphis
- Vanderbilt University, Nashville
招募中观察性研究
所有年龄段 · 所有性别 · 更新于 2026年7月6日 · NCT01351545A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Vanderbilt University Medical Center, Nashville
招募中2/3 期
18 岁及以上 · 所有性别 · 更新于 2026年4月30日 · NCT04256317Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
- St. Jude Children's Research Hospital, Memphis
招募中1 期
21 岁及以下 · 所有性别 · 更新于 2026年4月22日 · NCT05101551A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- TriStar Centennial Medical Center, Nashville
招募中1/2 期
12 岁及以上 · 所有性别 · 更新于 2026年3月24日 · NCT04988555A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
- Sarah Cannon Cancer Institute, Nashville
- Vanderbilt University Medical Center, Nashville
招募中1 期
12 岁及以上 · 所有性别 · 更新于 2026年3月16日 · NCT06994676A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- TriStar Bone Marrow Transplant, Nashville
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年3月13日 · NCT05735184A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
- Vanderbilt University, Nashville
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年2月9日 · NCT06950034CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
- St. Jude Children's Research Hospital, Memphis
招募中1 期
21 岁及以下 · 所有性别 · 更新于 2026年1月23日 · NCT06326463A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
- Sarah Cannon Research Institute, Nashville
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2025年9月24日 · NCT06501196HPC Offered for PRESERVE Expansion
- Tristar Centennial Medical Center, Nashville
招募中观察性研究
12 至 80 岁 · 所有性别 · 更新于 2025年8月28日 · NCT07145411Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
- TriStar Bone Marrow Transplant, Nashville
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2024年11月15日 · NCT06034275数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。